UCB onboards more autoimmune TCEs with $2.2B Candid buy
A preview of the next edition of BioWorld, May 4, 2026
A preview of the next edition of BioWorld, May 4, 2026
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.